Society for Clinical Research Sites Welcomes Covance as its Newest Global Impact Partner
Ellicott City, M.D., June 23, 2015 – The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today announced a two-year partnership with Laboratory Corporation of America® Holdings (LabCorp®) (LH: NYSE). Under the agreement, Covance Drug Development (Covance) will participate as a Global Impact Partner (GIP), a relationship designed to facilitate critical dialogue between industry stakeholders and clinical research sites.
“Covance’s commitment to partner with SCRS as a GIP demonstrates that establishing positive site relationships is a high priority for them,” commented Christine Pierre, SCRS President. “SCRS’ GIPs are focused on acknowledging the realities that today’s sites face, and actively addressing their challenges. SCRS is proud to welcome Covance as our newest Global Impact Partner.”
“Covance is committed to serving the clinical research community as a strong scientific partner in order to speed the development of innovative medicines that meet today’s global healthcare needs,” said Jill Johnston, Global Vice President, Site Activation, Informatics and Optimization, Covance. “Our work with SCRS will help us better understand the needs of our clinical research partners and ultimately improve service to our pharmaceutical and biotechnology clients.”
As a GIP, Covance will participate on the SCRS Global Impact Board at an executive level, and work in tandem with SCRS’ Leadership Council in the development and execution of strategic initiatives for SCRS.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
